High-Efficiency Gene Transfer to Autologous Rabbit Jugular Vein Grafts Using Adenovirus–Transferrin/Polylysine–DNA Complexes
Authors:
- Xin Ming RuanXRXin Ming Ruan
- Guoging LiuGLGuoging Liu
- Jack MatloffJMJack Matloff
- James ForresterJFJames Forrester
- Aurilo ChauxACAurilo Chaux
- 1 December 1994
- journal article
- Published by SAGE Publications in Human Gene Therapy
- Vol. 5 (12) , 1437-1443
Abstract
Within the first year, 15-20% of coronary artery saphenous bypass vein grafts (SVGs) occlude because of thrombosis or progressive intimal hyperplasia. One potential new strategy to reduce this complication would be to introduce antithrombotic or antiproliferative genes in vein grafts before implantation. The success of this approach requires an efficient DNA delivery system. In the present study we tested the feasibility of using adenovirus-transferrin/polylysine-DNA complexes (TfAdpl/DNA) to achieve high-efficiency gene transfer into vascular interposition vein grafts. All studies used the Escherichia coli LacZ (beta-galactosidase [beta-Gal]) reporter gene under the control of the cytomegalovirus (CMV) earlier promoter and enhancer (pCMV/LacZ). Autologous rabbit jugular vein segments were incubated ex vivo for 60 min in a solution of TfAdpl/DNA complexes (1.2 x 10(10) biotinylated adenovirus particles, 2,430 ng of streptavindylated polylysine. 10 micrograms of plasmid DNA, and 9 micrograms of transferrin-polylysine per ml), and then reimplanted across the ligated right carotid artery. Control veins were incubated in TfAdpl solution in which DNA was omitted. A total of six grafts were treated with TfAdpl/DNA, and two grafts were treated with TfAdpl. Veins were harvested 3 (n = 3) and 7 (n = 3) days later and beta-Gal activity was determined by X-Gal chromogen staining. All six TfAdpl/DNA-treated grafts stained intensely blue, whereas control grafts were negative. Microscopic examination of serial sections revealed intracellular blue granules consistent with beta-Gal activity to be present in all of the endothelial cells and in numerous medial and advential cells.(ABSTRACT TRUNCATED AT 250 WORDS)Keywords
This publication has 18 references indexed in Scilit:
- In vivo adenoviral vector-mediated gene transfer into balloon-injured rat carotid arteries.Circulation Research, 1993
- In vivo gene transfer and expression in normal uninjured blood vessels using replication-deficient recombinant adenovirus vectors.Circulation Research, 1993
- Cryopreserved allograft veins as alternative coronary artery bypass conduits: Early phase resultsThe Annals of Thoracic Surgery, 1992
- Coupling of adenovirus to transferrin-polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes.Proceedings of the National Academy of Sciences, 1992
- High-Efficiency Gene Transfer Mediated by Adenovirus Coupled to DNA–Polylysine ComplexesHuman Gene Therapy, 1992
- Direct in vivo gene transfer into the coronary and peripheral vasculatures of the intact dog.Circulation, 1991
- Evaluation of the Transfer and Expression in Mice of an Enzyme-Encoding Gene Using a Human Adenovirus VectorHuman Gene Therapy, 1990
- Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy. Results of a Veterans Administration Cooperative Study.Circulation, 1989
- Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass graftsJAMA, 1987
- Multivessel Coronary Revascularization Without Saphenous Vein: Long-term Results of Bilateral Internal Mammary Artery GraftingThe Annals of Thoracic Surgery, 1983